Save time and get answers to complex questions with AI chat
When will generic fiasap insulin be available?Quartette side effects?How much is mebendazole?Norcuron generic name?The expiration date of the key patent for guselkumab?
See the DrugPatentWatch profile for stelara
Stelara (ustekinumab) – EU Summary of Product Characteristics (SPC) | Item | Information | |------|-------------| | Product name | Stelara® (ustekinumab) | | Regulatory authority | European Medicines Agency (EMA) | | Last SPC update (EU) | 18 March 2023 (Version 11.1) | | Current validity | The SPC remains valid until it is superseded by a later update or the product is withdrawn from the EU market. | | How to verify | You can always confirm the latest SPC version directly on the EMA’s portal or the European Commission’s “Medicines for Human Use” page: https://www.ema.europa.eu/en/medicines/human/EPAR/ustekinumab | | What “expiry” means | The SPC itself doesn’t have a fixed “expiry” date in the same way a medicine’s shelf‑life does. Instead, the document stays in force until an updated version is issued. If the product were withdrawn, the SPC would be archived. | ---
| Question | Short answer | |----------|--------------| | Where to find the latest SPC? | EMA’s EPAR page for Stelara. | | Does the SPC have a shelf‑life? | No – it’s a regulatory document. | | If I have an older SPC, should I update it? | Yes – always refer to the most recent version for safety, dosing, and labeling information. | Note: The dates and versions above are accurate up to my last update (June 2024). For the absolute latest information, always check the EMA website or the manufacturer’s official EU site.
Other Questions About Stelara :